Next, we examined the proportion of apoptotic cells by transfecting the tRF-315 mimic into cells treated with cisplatin to determine whether tRF-315 could affect prostate cancer cell death using annexin V and PI staining. Here, ANXA5 is linked to prostate carcinoma.